Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access

October 18, 2015 — Results from a prospective randomized trial of transradial (TRI) versus transfemoral (TFO) access in ...

Home October 18, 2015
Home
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial
Feature | CT Angiography (CTA)

October 18, 2015 — New results from a multicenter, prospective study show that assessing fractional flow reserve ...

Home October 18, 2015
Home
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery
Feature | Peripheral Artery Disease (PAD)

October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a drug-coated balloon was superior to co ...

Home October 18, 2015
Home
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke
Feature | Stroke

October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with ...

Home October 16, 2015
Home
News | Stents Bioresorbable

October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials MEND ...

Home October 16, 2015
Home
Claret embolic protection, TAVR, cerebral protection
Feature | Heart Valve Technology

October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...

Home October 16, 2015
Home
ABSORB III trial, TCT 2015, bioresorbable vascular scaffold, BVS
Feature | Stents Bioresorbable

October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...

Home October 16, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...

Home October 15, 2015
Home
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results
Feature | Heart Valve Technology

October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...

Home October 15, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Biotronik has announced results from the BIOSOLVE-II trial, investigating the safety and clinical ...

Home October 15, 2015
Home
News | Drug-Eluting Balloons

October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-World ...

Home October 15, 2015
Home
News | Stents Bifurcation

October 14, 2015 — Tryton Medical Inc. announced results from the pivotal Tryton Confirmatory Study confirming the ...

Home October 14, 2015
Home
News | Angiographic Catheter

October 14, 2015 — On Oct. 7, 2015, Cook Medical initiated a voluntary recall for select sizes of Beacon Tip ...

Home October 14, 2015
Home
News | Cath Lab

October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest ...

Home October 09, 2015
Home
Subscribe Now